Shares of BTG plc (LON:BTG – Get Free Report) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 840 ($10.56) and traded as high as GBX 840 ($10.56). BTG shares last traded at GBX 840 ($10.56), with a volume of 271,742 shares trading hands.
BTG Price Performance
The company has a market cap of £3.26 billion and a price-to-earnings ratio of 29.47. The firm’s fifty day moving average price is GBX 840 and its 200-day moving average price is GBX 840.
About BTG
BTG plc acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications.
Recommended Stories
- Five stocks we like better than BTG
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Oil Titans Face Off: Exxon Mobil or Chevron for 2025 Gains?
- What is a Dividend King?
- Mining Stocks Back in the Spotlight: 3 Key Names to Watch
- The How and Why of Investing in Gold Stocks
- MarketBeat Week in Review – 12/16 – 12/20
Receive News & Ratings for BTG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG and related companies with MarketBeat.com's FREE daily email newsletter.
